Upcoming Webinars

No Upcoming Webinars Available

ALL WEBINARS

151 RESULTS

Sort By:

Is Alzheimer's an Autoimmune Disease?

Michael R. D'Andrea led this live discussion on 4 December 2003. Readers are invited to submit additional comments by using our Comments form at the bottom of the page. Transcript: Mike D'Andrea led this live discussion on 4 December 2003. Parti

Vascular Factors in Alzheimer's Disease

Jack de la Torre, David Bennett, and Julie Schneider led this live discussion on 21 April 2004. Readers are invited to submit additional comments by using our Comments form at the bottom of the page. Transcript: This live discussion with Jack de la Torre

Androgens, ApoE, and Alzheimer's Disease

This discussion was produced in collaboration with SAGE KE. Jacob Raber led this live discussion on 7 May 2004. Readers are invited to submit additional comments by using our Comments form at the bottom of the page. Transcript unavailable. Background Text

Protein Misfolding: An Unfolding Series of Discussions

Dominic Walsh led this live discussion on 9 June 2004. Readers are invited to submit additional comments by using our Comments form at the bottom of the page. Transcript: Dominic Walsh (University College Dublin) led this live discussion on 9 June 2004. P

Cast Call for Players: Healthy Aging Through Lean Living

Leigh Ann Henricksen and Howard J. Federoff led this live discussion on 17 August 2004. Readers are invited to submit additional comments by using our Comments form at the bottom of the page. Transcript: Live Discussion led by Leigh Ann Henricksen and How

Cell Death: Time to Push It Out of the Doldrums

We invite you to participate in this Forum Discussion with Yong Shen (Sun Health Research Institute). This discussion will not be hosted via our live discussion software. Instead, we will develop written exchanges between our participants and Yong Shen. T

Memantine: Implications for Treating Alzheimer's

Steven T. DeKosky and Bengt Winblad led this live discussion on how the addition of memantine to the clinician's toolbox will change the management of Alzheimer's disease.   Following its FDA approval last October, memantine is due to arrive in

Role and Control of Metal-Mediated Fibril Toxicity

David Allsop and Ashley Bush led this live discussion on 20 December 2004. Readers are invited to submit additional comments by using our Comments form at the bottom of the page. Transcript: Live Discussion led by David Allsop, Ashley Bush, and co-moderat

Is Alzheimer's a Type 3 Diabetes?

Suzanne de la Monte led this live discussion on 25 March 2005. Readers are invited to submit additional comments by using our Comments form at the bottom of the page. Transcript: Live Discussion led by Suzanne de la Monte on 25 March 2005. Participants: S

Have a topic idea for a webinar? We would love to hear it. Send an email to webinars [at] alzforum [dot] org.

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

DISEASE
TOPIC
BIOMOLECULE